RNPGX Mutual Fund Forecast & Price Targets

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

RNPGX Analyst Rating

Moderate Buy

230 Buy

47 Hold

0 Sell

Based on the consensus analyst ratings on 277 stocks held in RNPGX.

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

RNPGX Analyst Price Target

Average Price Target

$68.20

Based on 277 Wall Street analysts offering 12 month price targets to New Perspective Fund, Class R-6 Shares holdings in the last 3 months. The average price target is $68.20 with a high forecast of $81.18 and a low forecast of $52.83. The average price target represents a 11.36% change from the last price of $61.24.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"51":"$51","82":"$82","58.75":"$58.8","66.5":"$66.5","74.25":"$74.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":81.184,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$81.18</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":68.197,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$68.20</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":52.83,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$52.83</span>\n  </div></div>","useHTML":true}}],"tickPositions":[51,58.75,66.5,74.25,82],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,62.6,64.02953846153846,65.45907692307692,66.88861538461538,68.31815384615385,69.7476923076923,71.17723076923076,72.60676923076923,74.03630769230769,75.46584615384616,76.89538461538461,78.32492307692307,79.75446153846153,{"y":81.184,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,62.6,63.03053846153846,63.461076923076924,63.891615384615385,64.32215384615385,64.75269230769231,65.18323076923078,65.61376923076924,66.0443076923077,66.47484615384616,66.90538461538462,67.33592307692308,67.76646153846154,{"y":68.197,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,62.6,61.84846153846154,61.096923076923076,60.34538461538462,59.59384615384615,58.84230769230769,58.09076923076923,57.33923076923077,56.58769230769231,55.83615384615385,55.08461538461538,54.33307692307692,53.58153846153846,{"y":52.83,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":55.56,"date":1714521600000,"info":"<div>Price: <b>$56<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":58.18,"date":1717372800000,"info":"<div>Price: <b>$58<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":59.5,"date":1719792000000,"info":"<div>Price: <b>$60<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":58.72,"date":1722470400000,"info":"<div>Price: <b>$59<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":60.08,"date":1725321600000,"info":"<div>Price: <b>$60<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":62.33,"date":1727740800000,"info":"<div>Price: <b>$62<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":61.46,"date":1730419200000,"info":"<div>Price: <b>$61<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":63.5,"date":1733097600000,"info":"<div>Price: <b>$64<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":62.06,"date":1735776000000,"info":"<div>Price: <b>$62<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":64.21,"date":1738540800000,"info":"<div>Price: <b>$64<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":63.66,"date":1740960000000,"info":"<div>Price: <b>$64<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":61.33,"date":1743465600000,"info":"<div>Price: <b>$61<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":62.6,"date":1746057600000,"info":"<div>Price: <b>$63<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$81.18

Average Price Target$68.20

Lowest Price Target$52.83

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

RNPGX Stocks With Highest Upside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

SRPT

Sarepta Therapeutics Inc.

18 Buy

5 Hold

0 Sell

Strong Buy

$96.57

xxxxxxxxxxxxxxxxxxxxxxxxxxx

MUV2

Munich Reinsurance

2 Buy

10 Hold

0 Sell

Hold

$572.45

xxxxxxxxxxxxxxxxxxxxxxxxxxx

CRSP

Crispr Therapeutics

12 Buy

5 Hold

0 Sell

Moderate Buy

$67.47

xxxxxxxxxxxxxxxxxxxxxxxxxxx

ABBN

Abb Ltd (UK)

2 Buy

7 Hold

3 Sell

Hold

$45.57

xxxxxxxxxxxxxxxxxxxxxxxxxxx

EVO

Evolution Gaming

5 Buy

4 Hold

0 Sell

Moderate Buy

$1,047.33

RNPGX Stocks With Highest Downside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

PLTR

Palantir Technologies Inc.

3 Buy

11 Hold

4 Sell

Hold

$100.13

xxxxxxxxxxxxxxxxxxxxxxxxxxx

TSLA

Tesla Motors

16 Buy

10 Hold

11 Sell

Hold

$277.78

xxxxxxxxxxxxxxxxxxxxxxxxxxx

SOON

Sonova Holding

1 Buy

4 Hold

3 Sell

Hold

$261.75

xxxxxxxxxxxxxxxxxxxxxxxxxxx

ZURN

Zurich Insurance Group

3 Buy

4 Hold

4 Sell

Hold

$545.87

xxxxxxxxxxxxxxxxxxxxxxxxxxx

AMX

America Movil S.a.b. De C.v.

2 Buy

1 Hold

0 Sell

Moderate Buy

$16.15

RNPGX Mutual Fund FAQ

What is RNPGX’s average 12-month price target, according to analysts?

Based on analyst ratings, New Perspective Fund, Class R-6 Shares’s 12-month average price target is 68.20.

What is RNPGX’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for RNPGX, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is RNPGX a Buy, Sell or Hold?

New Perspective Fund, Class R-6 Shares has a consensus rating of Moderate Buy which is based on 230 buy ratings, 47 hold ratings and 0 sell ratings.

What is New Perspective Fund, Class R-6 Shares’s price target?

The average price target for New Perspective Fund, Class R-6 Shares is 68.20. This is based on 277 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $81.18 ,the lowest forecast is $52.83. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about New Perspective Fund, Class R-6 Shares?

New Perspective Fund, Class R-6 Shares’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 277 Wall Streets Analysts.

How can I buy shares of RNPGX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing